Has the market rally in biotech stocks hit a wall?

Name: Has the market rally in biotech stocks hit a wall?
Uploaded: 2014-04-12T00:19:18Z
Duration: P277S
Description: Thursday marked the single worst day for the Nasdaq since 2011. The once high-flying biotech and Internet shares tumbled, pulling the index below 4000 for the first time since Feb. 3. Hari Sreenivasan talks to Hugh Johnson of Hugh Johnson Advisors about what's behind investors' jitters and why tech and biotech tend to be more volatile than other stocks.

Clip: 04/11/2014 | 4m 37s

Thursday marked the single worst day for the Nasdaq since 2011. The once high-flying biotech and Internet shares tumbled, pulling the index below 4000 for the first time since Feb. 3. Hari Sreenivasan talks to Hugh Johnson of Hugh Johnson Advisors about what's behind investors' jitters and why tech and biotech tend to be more volatile than other stocks.

Aired: 04/11/14

Rating: NR

Problems Playing Video? | Closed Captioning

Major corporate funding for the PBS NewsHour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer …

Major corporate funding for the PBS NewsHour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and American Cruise Lines. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.

Has the market rally in biotech stocks hit a wall?

More News and Public Affairs Shows